Your session is about to expire
← Back to Search
Nicotinamide Riboside for Heart Failure (NRII Trial)
NRII Trial Summary
This trial will test whether the dietary supplement nicotinamide riboside (NR) can improve heart function in heart failure patients by increasing levels of the metabolite nicotinamide adenine dinucleotide (NAD+).
NRII Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNRII Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NRII Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have liver disease, severe kidney problems, untreated thyroid issues, severe complications from diabetes, or other health issues that make it too risky for you to have a heart pump implanted. You also must follow your doctor's orders and not abuse drugs or have problems getting to your medical appointments.My heart failure is not caused by common heart muscle issues.I have advanced heart failure from a heart muscle problem.I have severe heart failure with very poor heart function or need constant heart medication.I am scheduled for, or will soon be scheduled for, a heart pump implant.I am older than 18 years.
Frequently Asked Questions
Are participants still able to join this research endeavor?
"As indicated on clinicaltrials.gov, this medical research is actively searching for participants. It was initially uploaded to the website on September 26th 2020 and most recently revised on 30th of September 2022."
Have any other trials been conducted using Nicotinamide riboside as a treatment?
"Currently, 15 clinical trials for nicotinamide riboside are ongoing, with one being in the final Phase 3. Despite most of these studies taking place in Winston-Salem North carolina, 19 distinct medical centres are participating."
How many individuals are being included in the research study?
"Affirmative. The information on clinicaltrials.gov corroborates the fact that this study, which was originally posted on September 26th 2020 is currently recruiting patients. With 1 site in mind, 40 participants need to be recruited for the trial."
Share this study with friends
Copy Link
Messenger